Literature DB >> 9872387

Modulation of interleukin-8 activity by gingipains from Porphyromonas gingivalis: implications for pathogenicity of periodontal disease.

J Mikolajczyk-Pawlinska1, J Travis, J Potempa.   

Abstract

Gingipains are the major cysteine proteinases synthesized by Porphyromonas gingivalis which, in soluble form, are able to initially convert IL-8 (77 amino acid residues) to a more potent species truncated at the amino terminus, followed by slow degradation and destruction of chemokine biological activity. In contrast, the same enzymes when associated with bacterial outer-membrane blebs (vesicles), instantly degrade this chemokine. This division of enhancing and inactivating activity between soluble and membrane-bound gingipains can cause the compartmentalization of pro- and anti-inflammatory reactions to distal and proximal positions from bacterial plaque, respectively, which may explain why, despite the massive neutrophil accumulation at periodontitis sites, there is no elimination of infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9872387     DOI: 10.1016/s0014-5793(98)01461-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  44 in total

1.  Hydrolysis of interleukin-12 by Porphyromonas gingivalis major cysteine proteinases may affect local gamma interferon accumulation and the Th1 or Th2 T-cell phenotype in periodontitis.

Authors:  P L Yun; A A Decarlo; C Collyer; N Hunter
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalis.

Authors:  Eva A V Moelants; Gitte Loozen; Anneleen Mortier; Erik Martens; Ghislain Opdenakker; Danuta Mizgalska; Borys Szmigielski; Jan Potempa; Jo Van Damme; Wim Teughels; Paul Proost
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  The K1 serotype capsular polysaccharide of Porphyromonas gingivalis elicits chemokine production from murine macrophages that facilitates cell migration.

Authors:  Gabriela d'Empaire; Michael T Baer; Frank C Gibson
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

4.  The RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis Inactivate the Th2 cytokines interleukin-4 and interleukin-5.

Authors:  Vivian Tam; Neil M O'Brien-Simpson; Yu-Yen Chen; Colin J Sanderson; Beverley Kinnear; Eric C Reynolds
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

5.  Hemoglobin receptor protein from Porphyromonas gingivalis induces interleukin-8 production in human gingival epithelial cells through stimulation of the mitogen-activated protein kinase and NF-κB signal transduction pathways.

Authors:  Yuki Fujita; Masaaki Nakayama; Mariko Naito; Eiki Yamachika; Tetsuyoshi Inoue; Koji Nakayama; Seiji Iida; Naoya Ohara
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

Review 6.  Immune modulation by bacterial outer membrane vesicles.

Authors:  Maria Kaparakis-Liaskos; Richard L Ferrero
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

7.  Oral microbial biofilm stimulation of epithelial cell responses.

Authors:  Rebecca Peyyala; Sreenatha S Kirakodu; Karen F Novak; Jeffrey L Ebersole
Journal:  Cytokine       Date:  2012-01-21       Impact factor: 3.861

Review 8.  Bacterial proteases: targets for diagnostics and therapy.

Authors:  W E Kaman; J P Hays; H P Endtz; F J Bikker
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-18       Impact factor: 3.267

Review 9.  Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.

Authors:  Ian M Carroll; Nitsan Maharshak
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

Review 10.  Bacterial invasion of epithelial cells and spreading in periodontal tissue.

Authors:  Gena D Tribble; Richard J Lamont
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.